Search

Search results

Retina UK Knowledge-base: Refsum syndrome

Refsum syndrome

Refsum syndrome is an inherited metabolic condition, associated with elevated phytanic acid plasma levels, which impacts many body systems.

Retina UK Knowledge-base: Retinitis pigmentosa (RP)

Retinitis pigmentosa

Retinitis pigmentosa (RP) is an inherited eye condition that affects the photoreceptor cells responsible for capturing images from the visual field.

Retina UK Knowledge-base: Usher syndrome

Usher syndrome

Usher syndrome is an inherited condition that affects both hearing and vision.

Lottery balls in lots of different bright colours with different numbers printed on them in black

Lottery

Do you want to win up to £25,000 and feel good about supporting people with inherited progressive sight loss?! 50+ Retina UK supporters have won a cash prize so far.

The cover of the spring 2025 edition of Look Forward, featuring a photograph of comedian Chris McCausland on the cover

Look Forward – Spring 2025 – Issue 185

This edition of Look Forward includes the very latest news about an experimental therapy by Retina UK funded researchers, an article about one of our PhD students, a calendar of events in 2025, the usual research news round-up and lots more. Please take the time to complete our Sight Loss Survey, enclosed with this edition. You can find out more about the Survey.

The cover of the winter 2024 edition of Look Forward

Look Forward – Winter 2024 – Issue 184

Welcome to the winter edition of Look Forward. It’s packed full of news from our Conferences, the latest research news and an interview with Hassina Zeriri, one of our funded PhD students.

We have also included details of lots of ways you can get involved with Retina UK over the coming months, along with some suggested festive fundraising for the Christmas period.

Two Retina UK runners celebrating after finishing the TCS London Marathon.

Take on a challenge

With your challenge, you’ll help support people affected by inherited sight loss to lead better lives today and accelerate the search for treatments for the future.